Business Wire

Alvarez & Marsal Appoints Four New Managing Directors in Its Paris Office

Share

Leading global professional services firm Alvarez & Marsal (A&M) has announced the appointment of four Paris-based Managing Directors, Jonathan Gibbons, Guillaume Martinez, Frederic Steiner and Donatien Chenu, to the firm’s Global Transaction Advisory Group. These appointments advance A&M’s strategic expansion plans to meet local market demand in France, enhance its cross-border M&A offering and help clients address increasingly complex regional, European and global regulatory requirements.

The addition of Messrs. Gibbons, Martinez, Steiner and Chenu, all formerly with one of the Big Four in France, completes the latest phase of A&M’s European strategic growth plan following the launch of the firm’s Stockholm office and Nordics expansion in 2017 that added to existing transaction advisory activities in the U.K., Germany, and Netherlands. They will bolster A&M’s suite of integrated global transaction advisory services that provide clients with a differentiated offering for due diligence and transaction advisory requirements.

A&M’s market share continues to expand with the firm’s European practices experiencing strong growth over the past two years leading to work on a range of flagship European private equity deals. With A&M’s operational focus and market leading capabilities in Private Equity and Corporate Performance Improvement, A&M is uniquely placed to provide a differentiated approach to due diligence and take on the challenges of current market conditions faced by clients.

Antonio "Tony" Alvarez III, Managing Director and A&M’s European Practice lead, said, “These appointments support our global expansion strategy along with our capability building plans in France and Europe. New audit regulation and rotation rules are impacting the provision of non-audit services and generating greater conflicts in providing those services to clients. As growing numbers of Big Four professionals across Europe look beyond the traditional firms, A&M’s platform is acknowledged to be less restrictive enabling greater access for practice growth.”

Paul Aversano, Managing Director and Global Practice Leader of A&M’s Global Transaction Advisory Group, said, “The growth of our transaction advisory presence in France supports the firm’s commitment to meet local market needs and global market M&A demands with our unique and differentiated approach. These appointments are the latest of several growth areas in France and Europe for A&M to enable us to continue our European expansion.”

Managing Director and European Practice Lead with A&M’s Transaction Advisory Group, David Evans, added, “Jonathan’s, Guillaume’s, Frederic’s, and Donatien’s in-depth knowledge advances our ability to help private equity firms and corporate clients maximize value on a pan-European basis. We expect the French team to grow rapidly as client needs continue to escalate.”

Tarek Hosni, the France country leader and Managing Director with A&M Paris, stated, “The addition of these senior transaction professionals will enable us to increase our scale and service for French private equity firms as well as France based multinationals. A leading protagonist of positive transformation in France, we now also intend to deliver in France our internationally recognized expertise in transaction advisory services. This marks the start of our future growth plans for A&M France.”

A&M’s new Transaction Advisory Managing Directors have extensive cross-border and global transaction experience working with private equity and multi-national corporations throughout Europe and the world. The team’s collective experience spans numerous sectors including TMT, manufacturing, retail and consumer goods and financial services. For more information on Messrs. Gibbons, Martinez, Steiner and Chenu, please click on the links to their bios below:

Jonathan Gibbons

Guillaume Martinez

Frederic Steiner

Donatien Chenu

About Alvarez & Marsal

Companies, investors and government entities around the world turn to Alvarez & Marsal (A&M) when conventional approaches are not enough to make change and achieve results. Privately held since its founding in 1983, A&M is a leading global professional services firm that provides advisory, business performance improvement and turnaround management services.

With over 3000 people across four continents, we deliver tangible results for corporates, boards, private equity firms, law firms and government agencies facing complex challenges. Our senior leaders, and their teams, help organizations transform operations, catapult growth and accelerate results through decisive action. Comprised of experienced operators, world-class consultants, former regulators and industry authorities, A&M leverages its restructuring heritage to turn change into a strategic business asset, manage risk and unlock value at every stage of growth.

When action matters, find us at alvarezandmarsal.com. Follow A&M on LinkedInTwitter and Facebook.

Note to Editor:

About Alvarez & Marsal Global Transaction Advisory Group

A&M’s Global Transaction Advisory Group provides investors and lenders the answers needed to get the deal done. We combine our firm’s deep operational, industry and functional resources with Big Four-quality financial accounting and tax expertise to assess key deal drivers and focus on the root cause of any critical deal issues. As the largest transaction advisory practice outside the Big Four, our global integrated teams help private equity, sovereign wealth funds, family offices and hedge funds as well as corporate acquirers unlock value across the investment lifecycle.

The firm’s Global Transaction Advisory Group includes over 350 professionals in 22 offices throughout the U.S., Latin America, Europe, India and Asia. Our global team has extensive industry knowledge across multiple sectors including, but not limited to, dedicated industry verticals in healthcare, software & technology, energy and financial services.

Contact information

Alvarez & Marsal
Helene Willberg, +46 70 589 9763
Managing Director
or
Sandra Sokoloff, +1 212-763-9853
Senior Director of Global Public Relations
or
Margaret Cameron-Waller, +44 (0)207 7155202
Director of Marketing U.K. & Europe

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aroma Bit to Develop Smartphone Embeddable Ultra-compact Silicon CMOS Based Smell Sensor That Has Dog Nose Equivalent Resolution in 1mm Squared Die Size23.7.2019 04:30:00 EESTPress release

Aroma Bit launched a new subsidiary to develop the next generation smell sensor based on silicon CMOS sensor substrate that are ultra-compact, high resolution and low cost. The technology is realized by applying Aroma Bit developed smell sensor receptor membrane technology to ultra-sensitive silicon CMOS based ion imaging sensor technology developed by professor Kazuaki Sawada at Toyohashi University of Technology and associated companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005004/en/ Picture of 1mm squared die of silicon CMOS based smell sensor, with dog nose equivalent ~1,200 sensor pixels (Photo: Business Wire) Aroma Bit: http://www.aromabit.com Realizing smartphone embeddable smell sensor with dog nose equivalent ultra-high resolution smell sensor on only 1 millimeter square silicon die size Aroma Bit has developed and are currently selling a compact smell sensor that employs QCM or Quartz Crystal Micro

Logitech Delivers a Strong Start to Fiscal Year 2020 with Robust Sales and Profit Growth23.7.2019 04:00:00 EESTPress release

Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the first quarter of Fiscal Year 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005781/en/ Logitech delivers a strong start to Fiscal Year 2020 with robust sales and profit growth. (Graphic: Business Wire) Q1 sales were $644 million, up 6 percent in US dollars and 9 percent in constant currency, compared to Q1 of the prior year. Q1 GAAP operating income grew 46 percent to $47 million, compared to $32 million in the same quarter a year ago. Q1 GAAP earnings per share (EPS) grew 17 percent to $0.27, compared to $0.23 in the same quarter a year ago. Q1 non-GAAP operating income grew 11 percent to $67 million, compared to $61 million in the same quarter a year ago. Q1 non-GAAP EPS grew 15 percent to $0.39, compared to $0.34 in the same quarter a year ago. Cash flow from operations was $37 million, compared to $12 million in the sa

Gilead Presents New Data on Biktarvy® for the Treatment of HIV in Women and in Virologically Suppressed Patients With Known Resistance22.7.2019 19:00:00 EESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) today presented findings from two Phase 3 trials – a trial demonstrating the effectiveness of switching to Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets, B/F/TAF) in women, and a trial evaluating the potential for the single tablet regimen to be an effective treatment option in virologically suppressed patients with known resistance to nucleo(s)tide or non-nucleo(s)tide reverse transcriptase inhibitors (NRTIs or NNRTIs). The use of Biktarvy in patients with known drug resistance is investigational. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City. “These data presented at IAS provide new information about the treatment of HIV among women and patients with known drug resistance,” said Diana Brainard, MD, Senior Vice President, HIV and Emerging Viruses, Gilead Sciences. “The studies further demonstrate the potential for Biktarvy to be an

IBC Celebrates Young Talent in the Industry22.7.2019 18:36:00 EESTPress release

The media, entertainment and technology industry is changing. Attitudes are shifting, the next generation is consuming content differently to any before them and diverse and exciting content is being created to meet that demand in innovative formats. Driving this change is a new wave of industry talent, honoured at IBC with the first IBC Young Pioneer Award. Recognising the brightest, newest talent in the industry, this award will go to someone who has made a real impact with their passion, ambition and commitment and is making an outstanding contribution to our industry. “What we were looking for in the shortlist was, most importantly, real talent, a stand-out individual making a real difference in the industry,” said David Levine, VP, Programming - Kids, Europe & Africa/UK & Ireland, The Walt Disney Co. Ltd and Chair of the Judging Panel. “But we were also looking for a lasting legacy, for the Young Pioneer to be a leader today and a media guru of the future.” The call for entries so

Gilead Presents Proof-of-Concept Data for GS-6207, a First-in-Class Capsid Inhibitor, in People Living With HIV22.7.2019 18:00:00 EESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) today presented the first clinical data in people living with HIV on GS-6207, an investigational, novel, selective, first-in-class inhibitor of HIV capsid function. The Phase 1b data demonstrate the first proof of concept that HIV capsid inhibition can lead to significant declines in viral load in vivo. In addition, Gilead presented preclinical data demonstrating that resistance to GS-6207 in vitro did not lead to resistance to other classes of drugs used in the treatment of HIV. These data were presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City. GS-6207 is an investigational long-acting antiretroviral agent that can be delivered subcutaneously. GS-6207 recently received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) as a potential therapy for heavily treatment-experienced people living with multi-drug resistant HIV. GS-6207 acts in a novel way compared with current

Pacific Drilling Appoints James W. Harris as Chief Financial Officer22.7.2019 16:42:00 EESTPress release

Pacific Drilling S.A. (NYSE: PACD), one of the world’s leading deepwater drilling contractors, today announced that Pacific Drilling’s Board has appointed James W. Harris to serve as the Company’s Senior Vice President and Chief Financial Officer. Mr. Harris replaces Mr. Johannes (John) P. Boots, who, as previously announced, mutually agreed with the Company to step down from his position to pursue other opportunities. Mr. Harris has more than 30 years of experience in the energy industry in a variety of financial leadership, strategic and business planning roles. He most recently served as Executive Vice President, Drilling & Subsea for Forum Energy Technologies, Inc., having previously served Forum as Chief Financial Officer for 12 years. Bernie Wolford, the Company’s Chief Executive Officer, stated, “We sincerely appreciate the many contributions that John has made during his nearly 10-year tenure with Pacific Drilling and we wish him all the best in his future endeavors.” “We are e

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom